Biosimilars and Interchangeable Biologics

Discover the intricacies of biosimilar drugs in the updated second edition of Biosimilars and Interchangeable Biologics by Taylor & Francis Ltd. This comprehensive guide, spanning 258 pages, delves into strategic planning, legal considerations, patents, and regulatory pathways associated with biosimilars. Published in 2025, this essential resource also addresses the important aspects of global affordability.

Explore the intersection of science, technology, finance, ethics, and politics that shape the biosimilars landscape. The book offers valuable insights into development strategies and lifecycle management, making it a must-have for professionals in the pharmaceutical and healthcare industries. Enhance your understanding and stay ahead in the evolving field of biologics with this authoritative text.